Clinical Center of Montenegro

Podgorica 81000

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Triple Negative Breast Neoplasms

Studies at this site

• Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — Running, not enrolling
• A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer — Completed